| scholarly article | Q13442814 |
| P50 | author | Jane B. Lian | Q61090559 |
| Hanna Taipaleenmäki | Q61872622 | ||
| Janet L Stein | Q88625564 | ||
| Gary S Stein | Q88625567 | ||
| Jozef Zustin | Q114294035 | ||
| Eric Hesse | Q114422906 | ||
| Jacqueline Akech | Q117270528 | ||
| Andre J van Wijnen | Q60974897 | ||
| P2093 | author name string | Gillian Browne | |
| P2860 | cites work | Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes | Q24628676 |
| A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2 | Q28505869 | ||
| Metastasis to bone: causes, consequences and therapeutic opportunities | Q29614310 | ||
| miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. | Q30407836 | ||
| First microRNA mimic enters clinic | Q87067042 | ||
| Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions | Q30435146 | ||
| The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion | Q30447945 | ||
| Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines | Q33377379 | ||
| MicroRNAs in the control of metastatic bone disease | Q33821326 | ||
| TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development | Q33834762 | ||
| Mechanisms of bone metastasis | Q33977526 | ||
| Metastatic bone disease: role of transcription factors and future targets | Q34217531 | ||
| miR-214 targets ATF4 to inhibit bone formation. | Q34316430 | ||
| Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility | Q34989177 | ||
| FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion | Q35024427 | ||
| Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells | Q35755187 | ||
| MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review | Q36037933 | ||
| Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis | Q36402883 | ||
| MicroRNA control of bone formation and homeostasis | Q36661323 | ||
| Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis | Q36760255 | ||
| Cancer to bone: a fatal attraction | Q36884628 | ||
| MicroRNA functions in osteogenesis and dysfunctions in osteoporosis | Q36917893 | ||
| Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells | Q37000350 | ||
| MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma | Q37175182 | ||
| Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis | Q37322289 | ||
| Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer. | Q37323255 | ||
| Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression | Q37343805 | ||
| Dysregulation of developmental pathways in bone metastasis | Q37772654 | ||
| TGF-β in cancer and bone: implications for treatment of bone metastases | Q37779131 | ||
| Mechanisms in endocrinology: micro-RNAs: targets for enhancing osteoblast differentiation and bone formation | Q37956245 | ||
| Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas | Q39340986 | ||
| MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. | Q39582762 | ||
| Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis | Q39619751 | ||
| Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway | Q39956368 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 1433-1444 | |
| P577 | publication date | 2015-01-29 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease | |
| P478 | volume | 75 |
| Q37688549 | A microRNA/Runx1/Runx2 network regulates prostate tumor progression from onset to adenocarcinoma in TRAMP mice |
| Q37694746 | Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells |
| Q36069377 | Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4 |
| Q90655998 | Brain metastasis-related microRNAs in patients with advanced breast cancer |
| Q91782750 | Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment |
| Q47248660 | Cadherin 6 is activated by Epstein-Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma |
| Q28071486 | Calcium-Sensing Receptor in Breast Physiology and Cancer |
| Q90351467 | Circulating MicroRNAs and Blood-Brain-Barrier Function in Breast Cancer Metastasis |
| Q38835737 | Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer |
| Q64073566 | Development of Effective Therapeutics Targeting HER3 for Cancer Treatment |
| Q38735878 | Direct interaction between miR-203 and ZEB2 suppresses epithelial-mesenchymal transition signaling and reduces lung adenocarcinoma chemoresistance |
| Q40507688 | Downregulation of Potential Tumor Suppressor miR-203a by Promoter Methylation Contributes to the Invasiveness of Gastric Cardia Adenocarcinoma |
| Q37564406 | EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway |
| Q44871921 | Embryonic transcription factor SOX9 drives breast cancer endocrine resistance |
| Q33751161 | G9A performs important roles in the progression of breast cancer through upregulating its targets |
| Q64273660 | GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer |
| Q52646480 | Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations. |
| Q57474446 | Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation |
| Q64914390 | LINC01638 silencing inhibits cancer cell proliferation in colorectal adenocarcinoma through interaction with RUNX2. |
| Q91584997 | Long non-coding RNA heart and neural crest derivatives expressed 2-antisense RNA 1 overexpression inhibits the proliferation of cancer cells by reducing RUNX2 expression in triple-negative breast cancer |
| Q91757351 | MICROmanagement of Runx2 Function in Skeletal Cells |
| Q38625793 | Mechanisms of osteolytic and osteoblastic skeletal lesions |
| Q38818836 | Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development |
| Q64252822 | MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1 |
| Q92604393 | MiR-135-5p promotes osteoblast differentiation by targeting HIF1AN in MC3T3-E1 cells |
| Q91660683 | MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM |
| Q37620221 | MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39. |
| Q38910342 | MicroRNA Exert Macro Effects on Cancer Bone Metastasis |
| Q64100914 | MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes |
| Q37080584 | MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells. |
| Q37744995 | MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. |
| Q52978300 | MicroRNA-590-5p Stabilizes Runx2 by Targeting Smad7 During Osteoblast Differentiation. |
| Q26784033 | MicroRNAs and Potential Targets in Osteosarcoma: Review |
| Q64071367 | MicroRNA‑153 inhibits cell proliferation, migration, invasion and epithelial‑mesenchymal transition in breast cancer via direct targeting of RUNX2 |
| Q98465934 | Molecular mechanisms and clinical management of cancer bone metastasis |
| Q64077990 | Multilayer network analysis of miRNA and protein expression profiles in breast cancer patients |
| Q52718880 | Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention. |
| Q64930750 | Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene. |
| Q38514715 | Non-coding RNAs: Epigenetic regulators of bone development and homeostasis |
| Q88667939 | Nuclear organization mediates cancer-compromised genetic and epigenetic control |
| Q33875227 | Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological Methods |
| Q52601534 | Parathyroid hormone-induced down-regulation of miR-532-5p for matrix metalloproteinase-13 expression in rat osteoblasts. |
| Q46277870 | Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension. |
| Q53197894 | Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis. |
| Q39181420 | Runx Genes in Breast Cancer and the Mammary Lineage. |
| Q38928077 | Runx2 and microRNA regulation in bone and cartilage diseases |
| Q92972103 | Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness |
| Q37190115 | Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis |
| Q57816460 | Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2 |
| Q39654135 | Serum miRNA Signatures Are Indicative of Skeletal Fractures in Postmenopausal Women With and Without Type 2 Diabetes and Influence Osteogenic and Adipogenic Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells In Vitro. |
| Q64069885 | Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer |
| Q37718207 | Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment. |
| Q37396044 | TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma |
| Q58796351 | Targeting of HER3 with Functional Cooperative miRNAs Enhances Therapeutic Activity in HER2-Overexpressing Breast Cancer Cells |
| Q55092271 | Targeting the Metastatic Bone Microenvironment by MicroRNAs. |
| Q90435884 | The network of non-coding RNAs and their molecular targets in breast cancer |
| Q64946489 | The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs. |
| Q38808905 | The role of microRNAs in bone metastasis |
| Q38766996 | Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer |
| Q97426733 | Tumor dormancy in bone |
| Q36030509 | miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα. |
| Q41975973 | miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis |
| Q35780039 | miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A |
| Q41819664 | miR-203 and miR-320 Regulate Bone Morphogenetic Protein-2-Induced Osteoblast Differentiation by Targeting Distal-Less Homeobox 5 (Dlx5) |
| Q37344496 | miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancer |
| Q36548645 | miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1. |
| Q37465938 | miR-203 inhibits the traumatic heterotopic ossification by targeting Runx2. |
| Q55022278 | miR-208a-3p Suppresses Osteoblast Differentiation and Inhibits Bone Formation by Targeting ACVR1. |
| Q50068015 | miR‑203‑3p participates in the suppression of diabetes‑associated osteogenesis in the jaw bone through targeting Smad1. |
Search more.